Survival of patients with early-stage cervical cancer after sentinel lymph node biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)

IF 4.5 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Gynecologic oncology Pub Date : 2024-10-09 DOI:10.1016/j.ygyno.2024.07.028

David Cibula , Simone Marnitz , Jaroslav Klat , Jiri Jarkovsky , Giampaolo Di Martino , Luc Van Lonkhuijzen , Ignacio Zapardiel , Michal Zikan , Octavio Arencibia Sanchez , Francesco Raspagliesi , Jiri Presl , Lubos Minar , Ariel Gustavo Glickman , Marcela Ostojich , Almerinda Petiz , Špela Smrkolj , Toon Van Gorp , Roman Kocián , Kristyna Nemejcova , Christhardt Köhler

引用次数: 0

查看原文本刊更多论文

早期宫颈癌患者进行前哨淋巴结活检而不进行系统性盆腔淋巴结切除术后的生存率：SENTIX前瞻性单臂国际试验（CEEGOG CX-01；ENGOT-CX2）的主要终点结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecologic oncology 医学-妇产科学

CiteScore

8.60

自引率

6.40%

发文量

1062

审稿时长

37 days

期刊介绍： Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy